This study aims to evaluate the influence of a nanohydroxyapatite layer applied to the surface of titanium or titanium alloy implants on the intricate process of osseointegration and its effect on osteoblast cell lines, compared to uncoated implants. Additionally, the investigation scrutinizes various modifications of the coating and their consequential effects on bone and cell line biocompatibility. On the specific date of November 2023, an exhaustive electronic search was conducted in esteemed databases such as PubMed, Web of Science, and Scopus, utilizing the meticulously chosen keywords ((titanium) AND ((osteoblasts) and hydroxyapatite)). Methodologically, the systematic review meticulously adhered to the PRISMA protocol. Initially, a total of 1739 studies underwent scrutiny, with the elimination of 741 duplicate records. A further 972 articles were excluded on account of their incongruence with the predefined subjects. The ultimate compilation embraced 26 studies, with a predominant focus on the effects of nanohydroxyapatite coating in isolation. However, a subset of nine papers delved into the nuanced realm of its modifiers, encompassing materials such as chitosan, collagen, silver particles, or gelatine. Across many of the selected studies, the application of nanohydroxyapatite coating exhibited a proclivity to enhance the osseointegration process. The modifications thereof showcased a positive influence on cell lines, manifesting in increased cellular spread or the attenuation of bacterial activity. In clinical applications, this augmentation potentially translates into heightened implant stability, thereby amplifying the overall procedural success rate. This, in turn, renders nanohydroxyapatite-coated implants a viable and potentially advantageous option in clinical scenarios where non-modified implants may not suffice.

Objective: Yttria-stabilized tetragonal zirconia polycrystal (Y-TZP), a variant of zirconia (ZrO₂), has attracted interest as a substitute for titanium in dental and orthopedic implants, valued for its biocompatibility and aesthetics that resemble natural teeth. However, its bioinert surface limits osseointegration, making surface modifications such as calcium phosphate (CaP) coatings highly relevant. Materials and methods: The review process adhered to the PRISMA guidelines. Electronic searches of PubMed, Scopus, Web of Science, Embase, and Cochrane Library (July 2025) identified studies evaluating CaP-coated zirconia implants. Eligible studies included in vitro, in vivo, and preclinical investigations with a control group. Data on coating type, deposition method, and biological outcomes were extracted and analyzed. Results: A total of 27 studies were analyzed, featuring different calcium phosphate (CaP) coatings including β-tricalcium phosphate (β-TCP), hydroxyapatite (HA), octacalcium phosphate (OCP), and various composites. These coatings were applied using diverse techniques such as RF magnetron sputtering, sol–gel processing, biomimetic methods, and laser-based approaches. In multiple investigations, calcium phosphate coatings enhanced osteoblast attachment, proliferation, alkaline phosphatase (ALP) expression, and bone-to-implant contact (BIC) relative to unmodified zirconia surfaces. Multifunctional coatings incorporating growth factors, antibiotics, or nanoparticles showed additional benefits. Conclusion: CaP coatings enhance the bioactivity of zirconia implants and represent a promising strategy to overcome their inertness. Further standardized approaches and long-term studies are essential to verify their translational relevance.

The dynamic development of laser therapy in dentistry is associated, among other factors, with the bactericidal effect of the energy emitted by laser devices. Therefore, they are also helpful for decontamination. They are increasingly used in the treatment of peri-implantitis, a bacterial inflammation of peri-implant tissues that is the most severe late complication of implantation and a potential cause of implant loss. Therefore, this study aimed to assess the safety of laser decontamination of the implant surface with respect to its effect on the integrity of the implant structure. In the present study, blocks of the titanium alloys Ti-6Al4V and Ti6Al7Nb were fabricated using electron-beam powder bed fusion and laser powder bed fusion, respectively. These alloys, commonly used in implantology, here in the form of Ti block scaffolds, have been exposed to an Er³⁺:YAG laser under various parameters (energy range of 50–320 mJ, exposure times of 20 or 30 s), and their effects have been further observed. To determine the changes induced by the laser, the following techniques were used: X-ray diffraction (XRD), Rietveld refinement method, scanning electron microscopy (SEM) with EDS (Energy-dispersive X-ray Spectroscopy), and thermography. The results show that the proposed Ti6Al4V and Ti6Al7Nb scaffolds can be exposed to an Er³⁺:YAG laser without damage when the power is limited to 0.5 W.